Astrazeneca Pharma India reports net loss of Rs 1.23 crore in the September 2013 quarter

Sales rise 16.48% to Rs 115.58 crore

Net Loss of Astrazeneca Pharma India reported to Rs 1.23 crore in the quarter ended September 2013 as against net loss of Rs 45.12 crore during the previous quarter ended September 2012. Sales rose 16.48% to Rs 115.58 crore in the quarter ended September 2013 as against Rs 99.23 crore during the previous quarter ended September 2012. ParticularsQuarter EndedSep. 2013Sep. 2012% Var.Sales115.5899.23 16 OPM %-1.49-20.22 -PBDT1.62-18.32 LP PBT-0.72-20.82 97 NP-1.23-45.12 97

Powered by Capital Market - Live News